137 related articles for article (PubMed ID: 15926671)
1. Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures.
Nassar MN; Nesarikar VV; Lozano R; Huang Y; Palaniswamy V
Pharm Dev Technol; 2005; 10(2):227-32. PubMed ID: 15926671
[TBL] [Abstract][Full Text] [Related]
2. Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
Nassar MN; Nesarikar VN; Lozano R; Parker WL; Huang Y; Palaniswamy V; Xu W; Khaselev N
Pharm Dev Technol; 2004; 9(2):189-95. PubMed ID: 15202578
[TBL] [Abstract][Full Text] [Related]
3. Impurities in a lyophilized formulation of BMS-204352: identification and role of sanitizing agents.
Nassar MN; Nesarikar VV; Khaselev N; Lozano R
Pharm Dev Technol; 2006; 11(2):207-11. PubMed ID: 16749531
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a Lyophilized Drug Product to Other Solid and Liquid Media for the Extraction of Elastomeric Oligomers from a Butyl Rubber Stopper.
Zdravkovic SA
PDA J Pharm Sci Technol; 2017; 71(6):488-501. PubMed ID: 28928293
[TBL] [Abstract][Full Text] [Related]
5. Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.
Wang G; Fiske JD; Jennings SP; Tomasella FP; Palaniswamy VA; Ray KL
Pharm Dev Technol; 2008; 13(5):393-9. PubMed ID: 18720237
[TBL] [Abstract][Full Text] [Related]
6. Degradation of a fluoropyridinyl drug in capsule formulation: degradant identification, proposed degradation mechanism, and formulation optimization.
Chen JG; Markovitz DA; Yang AY; Rabel SR; Pang J; Dolinsky O; Wu LS; Alasandro M
Pharm Dev Technol; 2000; 5(4):561-70. PubMed ID: 11109255
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Levels of Rubber Stopper-Related Organic Leachables in Commercially Available Vialed Liquid and Lyophilized Drug Products.
Zdravkovic SA
Pharm Res; 2020 Mar; 37(4):76. PubMed ID: 32232571
[TBL] [Abstract][Full Text] [Related]
8. Structure elucidation and formation mechanistic study of a methylene-bridged pregabalin dimeric degradant in pregabalin extended-release tablets.
Tian Y; Lin J; Chen F; Wang S; Li D; Kuang Z; Zhu W; Li Y; Zheng T; Cao W; Zhu B; Tsai E; Fu L; Li M
Int J Pharm; 2020 Feb; 575():118910. PubMed ID: 31805310
[TBL] [Abstract][Full Text] [Related]
9. Solution degradant of mirabegron extended release tablets resulting from a Strecker-like reaction between mirabegron, minute amounts of hydrogen cyanide in acetonitrile, and formaldehyde in PEG during sample preparation.
Lin J; Huang T; Feng M; Li D; Zhao D; Wang J; Jin J; Zhu W; Li M
J Pharm Biomed Anal; 2019 May; 168():181-188. PubMed ID: 30818256
[TBL] [Abstract][Full Text] [Related]
10. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance.
Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K
J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824
[TBL] [Abstract][Full Text] [Related]
11. Structure Elucidation and Mechanistic Study of a New Dimeric Degradant in Ropinirole Hydrochloride Extended-Release Tablets.
Kuang Z; Huang T; Li D; Zhao D; Jin J; Lin J; Zhu W; Chen W; Li M; Shen W
Pharm Res; 2020 Jul; 37(7):136. PubMed ID: 32642838
[TBL] [Abstract][Full Text] [Related]
12. Profiling degradants of paclitaxel using liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry substructural techniques.
Volk KJ; Hill SE; Kerns EH; Lee MS
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):99-115. PubMed ID: 9300914
[TBL] [Abstract][Full Text] [Related]
13. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
Lin M; Li M; Buevich AV; Osterman R; Rustum AM
J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
[TBL] [Abstract][Full Text] [Related]
14. Lyophilization closures for protein based drugs.
DeGrazio F; Flynn K
J Parenter Sci Technol; 1992; 46(2):54-61. PubMed ID: 1588459
[TBL] [Abstract][Full Text] [Related]
15. Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.
Fujita M; Ueda T; Iwata M
Int J Pharm; 2010 Feb; 386(1-2):195-200. PubMed ID: 19931605
[TBL] [Abstract][Full Text] [Related]
16. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous relative UV response determination of known liquid drug product degradants by NMR spectroscopy.
Samuels ER; Wang T
J Pharm Biomed Anal; 2022 May; 213():114665. PubMed ID: 35217258
[TBL] [Abstract][Full Text] [Related]
18. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
Huang Y; Su BN; Marshall J; Miller SA
J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
[TBL] [Abstract][Full Text] [Related]
19. An artifactual solution degradant of pregabalin due to adduct formation with acetonitrile catalyzed by alkaline impurities during HPLC sample preparation.
Lin J; Liu X; Wang J; Li D; Zhu W; Chen W; Zhang X; Li Q; Li M
J Pharm Biomed Anal; 2019 Oct; 175():112788. PubMed ID: 31382116
[TBL] [Abstract][Full Text] [Related]
20. Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion.
Wu Y; Hwang TL; Algayer K; Xu W; Wang H; Procopio A; DeBusi L; Yang CY; Matuszewska B
J Pharm Biomed Anal; 2003 Dec; 33(5):999-1015. PubMed ID: 14656591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
